NHS Accused of 'Systematic Ignorance' Towards Rare Genetic Conditions
A damning report has revealed that millions of people living with rare genetic conditions across the UK are being 'systematically ignored' by the NHS, leading to inadequate care and prolonged suffering. The research, conducted by the charity Genetic Alliance UK, surveyed 290 individuals with rare conditions, uncovering widespread failures in diagnosis and treatment access.
Diagnosis Delays and Treatment Lottery
The findings indicate that one in four people waited at least three years for a diagnosis despite actively seeking NHS care. Furthermore, only one in 10 adults had a professional care coordinator to manage appointments and follow-ups, exacerbating the challenges faced by patients.
The report highlights an 'access lottery' for treatments, with just 5% of rare conditions having approved and licensed therapies available. Rare genetic conditions, such as Williams syndrome and Duchenne muscular dystrophy, affect more than 3.5 million people in the UK, equating to one in 17 individuals at some point in their lives.
Personal Struggles with Williams Syndrome
Ali Reed's daughter, Emma, has Williams syndrome, a condition affecting approximately one in 18,000 people in the UK. Caused by chromosomal issues, it can lead to delayed development, mild to moderate learning disabilities, and increased cardiovascular risks.
Reed recounted that healthcare professionals did not question Emma's development until she was nine months old, with diagnosis taking another year. 'During our diagnosis journey, what I found strange is that we had three or four healthcare professionals who had met other children with Williams syndrome, but didn't see it in Emma,' Reed said. 'Once you know what Williams syndrome is, it's not difficult to recognise people with it because they tend to share similar facial characteristics.'
Emma, now transitioning to adult care after 13 years under the same paediatrician, faces uncertainty. Reed expressed concern: 'Emma's paediatrician has been excellent and she's coordinated everything, but soon Emma will transition to adult services where she's seen by a GP. Only one in about 30 GPs have heard of Williams syndrome, so it's a concern to me that Emma won't get the level of care she needs.'
Systemic Failures and Recommendations
Nick Meade, chief executive of Genetic Alliance UK, criticised the NHS's rigid care pathways. 'In the main, the NHS does an excellent job of looking after us when we need it, but this isn't true for everyone. In fact, for those of us living in the UK with a rare condition, it can be quite the reverse,' he stated. 'Our healthcare model is made up of lots of different care pathways. If your symptoms fit neatly into one of these, then great. It means there will be a defined pathway of care for diagnosis and treatment. But these are rigid processes that tend to focus on the most common conditions.'
Meade added that the system lacks flexibility for rare, complex conditions, 'essentially penalising people for having the 'wrong' kind of condition and having a serious detrimental effect on the millions of people in our country living with a rare condition.'
An analysis of the 163 most prevalent rare conditions from the European Orphanet database found that only 26% were supported by National Institute for Health and Care Excellence guidance. For 79 conditions with identifiable commissioners in England, over 55% lacked a specialised service.
The charity has called for urgent action, recommending the funding and development of a comprehensive rare condition registry across the UK, alongside increased research investment into rare genetic conditions to improve diagnosis times and treatment accessibility.
